Edris Hoseinzadeh | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr.Edris Hoseinzadeh | Developmental Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Edris Hoseinzadeh | Saveh University of Medical Sciences | Iran

Dr. Edris Hoseinzadeh is an Associate Professor of Environmental Health Engineering at Saveh University of Medical Sciences, Iran. He is a highly accomplished environmental health engineer recognized for his innovative research on sustainable solutions for water and wastewater treatment, air pollution control, and waste valorization. His scientific expertise spans advanced oxidation processes, electrochemical systems, nanotechnology applications, and the integration of artificial intelligence in smart remediation technologies. Dr. Hoseinzadeh has authored over 90 research papers, holds multiple patents, and has achieved an h-index of 18 with more than 2,500 citations, reflecting his significant impact in the field. His work addresses critical global challenges such as emerging contaminants, pharmaceutical pollutants, microplastics, and antibiotic-resistant genes, with a focus on resource recovery and circular economy principles. As Head of the Department of Environmental Health Engineering at Saveh University, he has also demonstrated strong leadership and academic mentorship, guiding over 15 graduate theses and serving as Founder and Editor-in-Chief of the HOZAN Journal of Environmental Sciences. Dr. Hoseinzadeh’s research combines scientific rigor with practical innovation, contributing to the advancement of environmental sustainability and public health protection.

Profiles: Scopus | Orcid | Google Scholar | Research Gate | Linked In

Featured Publications

(2025). Factors influencing source separation intention for improving waste management in educational places: A case study for a university campus. International Journal of Environmental Health Engineering.

 (2024). Microplastics contamination in popular soft drinks and non-alcoholic beverages marketed in Iran: Quantity and characteristics. Results in Engineering.

 (2024). Soil pollution indices and health risk assessment of metal(loid)s in the agricultural soil of pistachio orchards. Scientific Reports.

 (2024). Treatment of real carwash wastewater using high-efficiency and energy-saving electrocoagulation technique. Sustainable Chemistry and Pharmacy.

(2024). Water recovery and treatment of spent filter backwash from drinking water using chemical reactor–ultrafiltration process. Journal of Water Process Engineering.

(2024). Utilization of local corn (Zea mays) wastes for bioethanol production by separate hydrolysis and fermentation. Journal of Hazardous Materials Advances.

Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo S. Osorio is a tenured Associate Professor of Psychiatry and Radiology at NYU Grossman School of Medicine, where he directs the Healthy Brain Aging and Sleep Center and serves as Director of the Biomarker Core within the NYU Alzheimer’s Disease Research Center. A physician-scientist, Dr. Osorio investigates the interplay of sleep, vascular, and inflammatory mechanisms in Alzheimer’s disease, integrating multimodal biomarkers, neuroimaging, and detailed clinical phenotyping. He has led several landmark studies, including trials on sleep apnea, amyloid and tau accumulation, brain energetics, and locus coeruleus dysfunction, exploring how sleep and metabolic factors influence cognitive decline and neurodegeneration. His work has significantly advanced translational biomarker development, assay harmonization, and inclusive recruitment in aging research. Dr. Osorio has published over 130 peer-reviewed articles in top journals such as JAMA Neurology, Annals of Neurology, Sleep, Alzheimer’s & Dementia, Lancet, and Brain, contributing to more than 8,369 citing documents, with a total citation count of 9,893 and an h-index of 44. He serves on multiple editorial boards, including Sleep Medicine Reports, and has provided expert peer review for leading journals worldwide. His collaborative network spans the NYU Alzheimer’s Disease Research Center, Mount Sinai, the ENIGMA-Sleep Consortium, and numerous national and international aging and sleep research initiatives, mentoring the next generation of clinician-scientists while shaping the field of sleep and neurodegeneration.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  1. Author(s). (Year). Disordered sleep and painful diabetic neuropathy (PDN): A review of the literature on pathophysiology, pharmacologic and nonpharmacologic treatment options, and future directions. Journal Name, Volume(Issue), pages.

  2. Author(s). (2025). EEG slow oscillations and overnight spatial navigational memory performance in CPAP-treated obstructive sleep apnea. Sleep, Volume(Issue), pages.

  3. Author(s). (2025). High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer’s disease dementia. Alzheimer’s & Dementia, Volume(Issue), pages.

  4. Author(s). (2025). Impact of Alzheimer’s disease on sleep in adults with Down syndrome. Alzheimer’s & Dementia, Volume(Issue), pages.

  5. Author(s). (2025). Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. Journal of Clinical Investigation, Volume(Issue), pages.

  6. Author(s). (2025). The stability of slow-wave sleep and EEG oscillations across two consecutive nights of laboratory polysomnography in cognitively normal older adults. Journal of Sleep Research, Volume(Issue), pages.

  7. Author(s). (2025). Two-year longitudinal outcomes of subjective cognitive decline in Hispanics compared to non-Hispanic Whites. Journal of Geriatric Psychiatry and Neurology, Volume(Issue), pages.

  8. Author(s). (Year). Enhancing sleep, wakefulness, and cognition with transcranial photobiomodulation: A systematic review. Journal Name, Volume(Issue), pages.

  9. Author(s). (2024). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Journal of Alzheimer’s Disease, Volume(Issue), pages.

  10. Author(s). (2024). The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity and Ageing, Volume(Issue), pages.

Noreen Kamal | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Dalhousie University | Canada

Dr. Noreen Kamal, Ph.D., P.Eng., is an Associate Professor of Industrial Engineering at Dalhousie University, Canada, with cross-appointments in the Departments of Community Health and Epidemiology and Medicine (Neurology). Her research lies at the intersection of health systems engineering and clinical neuroscience, focusing on the optimization of stroke care systems, development of data-driven quality improvement frameworks, and evaluation of biomedical devices for stroke rehabilitation. Dr. Kamal has played a pivotal role in advancing integrated approaches to enhance the efficiency, safety, and accessibility of acute stroke services across Canada. Prior to joining Dalhousie University, she held academic and leadership positions at the University of Calgary and the University of British Columbia, contributing extensively to clinical research and health technology innovation. Her work bridges engineering, medicine, and health policy, emphasizing interdisciplinary collaboration and patient-centered outcomes. With 107 scientific publications, 8,033 citations, and an h-index of 22, Dr. Kamal has established herself as a recognized scholar in healthcare systems improvement and translational neuroscience. Her scholarly and professional contributions continue to drive evidence-based innovation in stroke systems of care, supporting better clinical outcomes and sustainable health service delivery.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured Publications

Author(s). (2025). Exploring differences in stroke treatment between urban and rural hospitals: A thematic analysis of practices in Canada. Canadian Journal of Neurological Sciences.

Author(s). (2025). Designing a patient outcome clinical assessment tool for modified Rankin Scale: “You feel the same way too”. Informatics.

Author(s). (2025). Predicting ischemic stroke patients to transfer for endovascular thrombectomy using machine learning: A case study. Healthcare (Switzerland).

Author(s). (2025). Incident prescriptions for common cardiovascular medications: Comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems. BMC Cardiovascular Disorders.

Author(s). (2025). Rising out-of-hospital mortality in Canada during 2020–2022: A striking impact observed among young adults. Canadian Journal of Public Health.

Author(s). (2025). Discrete event simulation model of an acute stroke treatment process at a comprehensive stroke center: Determining the ideal improvement strategies for reducing treatment times. Journal of the Neurological Sciences.

Author(s). (2025). Validation of the Passive Surveillance Stroke Severity Score in three Canadian provinces. Canadian Journal of Neurological Sciences.

Author(s). (2025). A stochastic optimization model for designing disaster relief networks with congestion, disruption and distributional ambiguity. Infor.

Author(s). (2025). Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: A stepped-wedge trial. Frontiers in Neurology.

Author(s). (2025). The acute stroke system of treatment across Canada: Findings from a national stroke centre survey. Canadian Journal of Neurological Sciences.

Nasar Ata | Neurology | Best Researcher Award

Published on by Neuroscientists

Mr. Nasar Ata | Neurology | Best Researcher Award

Dr. S. M. Nasar Ata is a researcher in the Department of Neurology at Henry Ford Hospital, Detroit, USA, specializing in artificial intelligence applications in neuroscience. His work focuses on developing machine learning and soft computing–based algorithms such as CNN, ANN, SVM, and MLR for detecting and predicting brain-based disorders, including Multiple Sclerosis. He integrates metabolomics and imaging clinical data to identify biomarkers and construct predictive models for neurological and metabolic diseases. Dr. Ata collaborates with research centers such as JNMC and IBRC AMU on brain tumor prediction from MRI data and with RCDR AMU on diabetes-related model development. His research contributions include several submitted papers on metabolite prediction, deep learning in brain tumor detection, and molecular mechanisms underlying neurodegeneration and cancer. He has also authored the textbook Basics of Bio-Sciences and actively participates in scientific discussions and editorial work. With 3 published documents, 7 citations, and an h-index of 2, Dr. Ata’s growing research profile reflects his commitment to advancing data-driven neurological diagnostics through AI and biostatistical innovation.

Profiles: Scopus | Research Gate

Featured Publication

Corrigendum to “Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data” [Multiple Sclerosis and Related Disorders, 92, 105942 (2024)]. (2024). Multiple Sclerosis and Related Disorders, 95, 106321.

Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | University of Sousse | Tunisia

Dr. Chahra Chbili is an Assistant Professor of Pharmacology at the Higher School of Health Sciences and Techniques of Sousse (ESSTSS) and a member of the Research Laboratory of Metabolic Biophysics and Applied Pharmacology (LR/12ES02) at the Faculty of Medicine Ibn El Jazzar of Sousse, Tunisia. Her academic journey spans extensive training in biological sciences, genetics, and medical biotechnology, with a Ph.D. earned with highest honors for her work on the pharmacokinetic and pharmacogenetic study of carbamazepine therapy in epileptic and bipolar patients. Dr. Chbili’s research focuses on pharmacogenetics, pharmacokinetics, and the molecular mechanisms underlying drug efficacy and toxicity. She has contributed significantly to studies exploring the genetic determinants of drug metabolism, including investigations into glutathione-S-transferases in tuberculosis patients with drug-induced hepatotoxicity. Skilled in advanced laboratory techniques such as PCR, FISH, ELISA, and HPLC-MS, she has developed expertise in integrating molecular biology with clinical pharmacology. Dr. Chbili has authored 17 scientific documents, accumulated 138 citations across 123 indexed works, and maintains an h-index of 7, reflecting her impactful contributions to pharmacological and biomedical research in Tunisia and beyond.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

Chbili, C., Mrad, S., Graiet, H., Selmi, M., Maatoug, J., Maoua, M., Abdellaoui, L., Mrizek, N., Nouira, M., Ben Fredj, M., et al. (2024). Randomized, placebo-controlled pilot study investigating the effects of Laurus nobilis tea on lipid profiles and oxidative stress biomarkers in healthy North African volunteers. The North African Journal of Food and Nutrition Research, 8(17), 86–98.

Chbili, C., Fathallah, N., Laadhari, C., Ouni, B., Saguem, S., Ben Fredj, M., Abdelghani, A., Ben Saad, H., & Ben Salem, C. (2022). Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study. Gene, 808, 146019.

Rebai, A., Chbili, C., Ben Amor, S., Hassine, A., Ben Ammou, S., & Saguem, S. (2021). Effects of glutathione S-transferase M1 and T1 deletions on Parkinson’s disease risk among a North African population. Revue Neurologique, 177(1–2), 93–99.

Chbili, C. (2021, August 22). The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson’s disease: A randomized controlled pilot study. Journal article.

Chbili, C., Maoua, M., Selmi, M., Mrad, S., Khairi, H., Limem, K., Mrizek, N., Saguem, S., & Ben Fredj, M. (2020). Evaluation of daily Laurus nobilis tea consumption on lipid profile biomarkers in healthy volunteers. Journal of the American College of Nutrition, 39(6), 518–526.

Rebai, A., Reçber, T., Nemutlu, E., Chbili, C., Kurbanoglu, S., Kir, S., Ben Amor, S., Özkan, S. A., & Saguem, S. (2020). GC-MS based metabolic profiling of Parkinson’s disease with glutathione S-transferase M1 and T1 polymorphism in Tunisian patients. Combinatorial Chemistry and High Throughput Screening, 23(8), 785–794.

Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Published on by Neuroscientists

Prof. Dr. Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Poznan University of Medical Sciences | Poland

Professor Elzbieta Paszynska is a distinguished expert in dentistry, serving as Chair of the Department of Integrated Dentistry and Chair of Community Dentistry at Poznan University of Medical Sciences. Her academic focus includes community dentistry, adult comprehensive dental treatment, dental materials, and clinical research in oral health, particularly in patients with eating disorders. She has led numerous significant research projects, including studies on salivary biomarkers, oral health status in eating disorders, and the caries-preventive effects of hydroxyapatite toothpaste in children and adults, collaborating with multiple international institutions. Her research has contributed to over 70 scientific documents with more than 598 citations and an h-index of 13. She has published high-impact works in journals such as Scientific Reports, Frontiers in Public Health, Frontiers in Psychiatry, Nutrients, and the Journal of Dentistry. Her contributions include interdisciplinary projects integrating dentistry, ethics, and public health, and she has coordinated large-scale EU-funded projects and international collaborations. Her work has been recognized with multiple institutional and national awards for scientific excellence, teaching, and professional contributions to dentistry, as well as honors from professional dental associations. She is an active member of national boards and promotes innovation in dental education and research.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • Obesity and central accumulation of fat in school-age children with attention-deficit/hyperactivity disorder. (2025). Scientific Reports.

  • Miescher’s Cheilitis as a Diagnostic and Therapeutic Challenge—A Case Report. (2025). Medicina, Kaunas, Lithuania.

  • Prevalence of Toothache in Adults: A Meta-Analysis of Worldwide Studies. (2025).

  • Pain experience and behavior management: efficacy of photobiomodulation as an adjunct to local anesthesia in MIH patients—a randomized split-mouth clinical study. (2025). Frontiers in Neurology.

  • Clinical evidence of caries prevention by hydroxyapatite: An updated systematic review and meta-analysis. (2025).

Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Amrita Vishwa Vidyapeetham | India

Ms. Priyadharshini Veeralakshmanan is a dedicated PhD scholar at Amrita Vishwa Vidyapeetham, specializing in Medical Oncology with a focus on Breast Cancer Immunology and the immunosuppressive tumour microenvironment (TME), particularly in Triple-Negative Breast Cancer (TNBC). Her doctoral research involves a Phase 2/3 open-label pilot clinical trial to evaluate neoadjuvant metronomic chemotherapy for modulating the TME and enhancing chemo- and immunotherapy responses, quantifying immunosuppressive cells and tumour-infiltrating lymphocytes from blood and tumour tissue. She holds an M.Sc. in Physician Assistant (Medical Oncology) and a B.Sc. in Physician Assistant (General Medicine), with extensive clinical training in oncology, hematology, surgical oncology, radiation oncology, and palliative care. Priyadharshini has strong expertise in flow cytometry, cell culture, in vitro drug testing, cytotoxicity assays, systematic reviews, meta-analysis, and clinical trial design, using advanced analytical tools such as FlowJo, SPSS, and GraphPad Prism. She has authored several publications, with an h-index of 3, over 7 documents, and more than 50 citations. A member of ESMO, ASCO, and I-OSI, she is committed to advancing cancer research, translating innovative findings into clinical practice to improve patient outcomes globally.

Profiles: Orcid | Linked In

Featured publications

Veeralakshmanan, P., Jose, W. M., Udayakumaran, S., Bindhu, M. R., Dutta, D., Rajesh, K., Kavalagunta, S., Bhaskaran, R., Haridas, N. K., Rakesh, M. P., et al. (2025). Multimodal management and outcome of pediatric and adolescent malignant central nervous system tumors: A single‐center retrospective study. Malignancy Spectrum.

Surendran, H. P., Sah, S. K., Veeralakshmanan, P., Nair, P., Ashok, H. P., Unnikrishnan, M. K., Kalavagunta, S., Sasidharan, A., Chandran, D., Poornachary, N. M., et al. (2025). Efficacy of hippocampal avoidance whole brain radiotherapy to preserve the cognitive functions among brain metastasis patients: Systematic review and meta-analysis. Neurology India, 73(5), 715–725.

Irene Litvan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.

Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Borghesiana Veterinary Clinic | Italy

Mrs. Claudia Pauciulo is the Head of the Neurology and Neurosurgery Department at Borghesiana Veterinary Clinic in Rome, Italy, and a certified veterinary neurologist completing her ECVN Residency. She holds a Master’s Degree in Diagnostic Imaging and a GP Certificate in Neurology, combining strong academic training with extensive clinical experience in advanced diagnostics (MRI, CT), neurosurgery, and case management. Her research focuses on feline and canine hyperesthesia syndromes, central nervous system lymphoma, intervertebral disc disease, and peripheral neuropathies. Dr. Pauciulo has published as both first author and coauthor in high-impact, peer-reviewed journals, including the Journal of Veterinary Internal Medicine, Journal of the American Veterinary Medical Association, Veterinary Record Case Reports, Journal of Small Animal Practice, and Veterinary Sciences (MDPI). She maintains an active citation record with growing visibility in Scopus- and SCI-indexed publications. Her current h-index is 2, with a total of 10 citations across multiple publications. Through her collaborative research with leading ECVN diplomates and contributions to international neurology congresses, Dr. Pauciulo continues to advance veterinary neuroscience, integrating clinical excellence with innovative research to improve evidence-based therapeutic strategies for neurological disorders in companion animals.

Profiles: Orcid | Linked In

Featured Publication

Pauciulo, C., & Gallucci, A. (2025, September 25). Long‐term outcome of presumptive idiopathic hyperesthesia syndrome in a dog treated with fluoxetine. Veterinary Record Case Reports.

Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Dr. Jaleel Miyan | The University of Manchester | United Kingdom

Dr. Jaleel Ahmad Miyan is a distinguished British neuroscientist and Senior Lecturer at the Faculty of Biology, Medicine & Health, Division of Neuroscience, University of Manchester, with a long-standing career dedicated to understanding cerebrospinal fluid (CSF) physiology and its role in neurological disorders. As President of the Society for Research into Hydrocephalus & Spina Bifida and a Fellow of both the Higher Education Academy and the Royal Society of Biology, he is recognized internationally for his expertise in cerebral folate metabolism and hydrocephalus research. His principal work focuses on fetal-onset and neonatal hydrocephalus, aiming to develop a non-invasive, non-surgical treatment to address global disparities in care. Miyan has supervised numerous PhD and Masters students, postdoctoral researchers, and technicians, fostering research excellence. He has published over 120 peer-reviewed research papers and reviews, with an h-index of 34, and his work has garnered substantial citations, reflecting his impact in neuroscience. He has served on editorial boards, contributed to major research projects, and secured significant funding for studies on folate metabolism in neurological conditions. Miyan’s scholarship is accessible through his ResearchGate, Orcid, and Google Scholar profiles, showcasing his profound contributions to advancing neuroscience and improving treatments for devastating neurological conditions.

Profiles : Google Scholar | Orcid | Research Gate

Featured Publications

Downing, J. E. G., & Miyan, J. A. (2000). Neural immunoregulation: Emerging roles for nerves in immune homeostasis and disease. Immunology Today, 21(6), 281–289.

Assas, B. M., Pennock, J. I., & Miyan, J. A. (2014). Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis. Frontiers in Neuroscience, 8, 23.

Miyan, J. A., Nabiyouni, M., & Zendah, M. (2003). Development of the brain: A vital role for cerebrospinal fluid. Canadian Journal of Physiology and Pharmacology, 81(4), 317–328.

Gazi, E., Dwyer, J., Lockyer, N. P., Miyan, J., Gardner, P., Hart, C., & Brown, M., et al. (2005). Fixation protocols for subcellular imaging by synchrotron‐based Fourier transform infrared microspectroscopy. Biopolymers: Original Research on Biomolecules, 77(1), 18–30.

Mashayekhi, F., Draper, C. E., Bannister, C. M., Pourghasem, M., & Miyan, J. A., et al. (2002). Deficient cortical development in the hydrocephalic Texas (H‐Tx) rat: A role for CSF. Brain, 125(8), 1859–1874.

Owen‐Lynch, P. J., Draper, C. E., Mashayekhi, F., Bannister, C. M., & Miyan, J. A. (2003). Defective cell cycle control underlies abnormal cortical development in the hydrocephalic Texas rat. Brain, 126(3), 623–631.